These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26345151)

  • 1. The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy.
    Shah SL; Lacy BE; DiBaise JK; Vela MF; Crowell MD
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1093-100. PubMed ID: 26345151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE; Chehade R; Crowell MD
    Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.
    Viazis N; Karamanolis GP; Anastasiou J; Keyoglou A; Vlachogiannakos J; Ladas SD; Karamanolis DG
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1450-5. PubMed ID: 24047861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
    Blondeau K; Boecxstaens V; Van Oudenhove L; Farré R; Boeckxstaens G; Tack J
    Neurogastroenterol Motil; 2011 Aug; 23(8):724-e327. PubMed ID: 21535319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux.
    Crowell MD; Bradley A; Hansel S; Dionisio P; Kim HJ; Decker GA; DiBaise JK; Sharma VK
    Am J Gastroenterol; 2009 Mar; 104(3):553-9. PubMed ID: 19223881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
    Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
    Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
    Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
    Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
    Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
    Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy.
    Garrean CP; Zhang Q; Gonsalves N; Hirano I
    Am J Gastroenterol; 2008 Jul; 103(7):1631-7. PubMed ID: 18557714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.
    Frazzoni L; Frazzoni M; de Bortoli N; Tolone S; Furnari M; Martinucci I; Bertani H; Marchi S; Conigliaro R; Fuccio L; Savarino V; Savarino E
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28543861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
    Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
    Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.
    Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO
    Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Ambulatory pH Monitoring in Patients with Gastroesophageal Reflux Rendered Asymptomatic with Proton Pump Inhibitor Therapy.
    Lin D; Triadafilopoulos G
    Dig Dis Sci; 2015 May; 60(5):1343-9. PubMed ID: 25135815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors.
    Fouad YM; Katz PO; Castell DO
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1467-71. PubMed ID: 10571603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
    Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
    Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.